Subcutaneous Immunotherapy in Patients Sensitized to Dermatophagoides Pteronyssinus (DPT)

NCT01489020 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinoconjunctivitis

Interventions

BIOLOGICAL: subcutaneous immunotherapy with DPT extract
BIOLOGICAL: Subcutaneous depot placebo

Sponsor

Roxall Medicina España S.A